Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Parmax Pharma Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
Net Profit/Loss Before Extraordinary Items And Tax-2.40-5.660.050.301.21
      
Net CashFlow From Operating Activities-0.96-0.190.330.753.53
Net Cash Used In Investing Activities-0.70-1.59-0.94-1.53-3.15
Net Cash Used From Financing Activities1.401.43-0.04-0.910.40
      
Net Inc/Dec In Cash And Cash Equivalents-0.26-0.35-0.65-1.690.78
Cash And Cash Equivalents Begin of Year0.050.411.052.751.77
Cash And Cash Equivalents End Of Year-0.210.060.411.052.55
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
Net Profit/Loss Before Extraordinary Items And Tax-2.40
Net CashFlow From Operating Activities-0.96
Net Cash Used In Investing Activities-0.70
Net Cash Used From Financing Activities1.40
Net Inc/Dec In Cash And Cash Equivalents-0.26
Cash And Cash Equivalents Begin of Year0.05
Cash And Cash Equivalents End Of Year-0.21